MedTrace Logo

Reduction of Catheterization Radiation Exposure Pad

NCT03139968 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 766

Last updated 2023-01-31

No results posted yet for this study

Summary

The RECAP-trial is a randomized controlled, double blinded, superiority trial studying the efficacy of the RADPAD®, a protective drape, that potentially reduces the scattered radiation received by the operator during diagnostic angiograms and percutaneous coronary interventions.

Conditions

  • Radiation; Exposure Occupational
  • Coronary Interventions

Interventions

DEVICE

(sham) radiation absorbing drape (RADPAD®)

Sponsors & Collaborators

  • J.P.S Henriques

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-16
Primary Completion
2017-06-01
Completion
2017-10-01

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03139968 on ClinicalTrials.gov